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Gene Regulation at a Distance:
Higher-Order Chromatin Folding and
the Coordinated Control of Gene
Transcription at the Epidermal
Differentiation Complex Locus
Michael Y. Fessing1
Chromatin structure and spatial interactions between proximal and distal gene
regulatory elements, including gene core promoters and enhancers, are important
in the control of gene transcription. In this issue, Oh et al. characterized an AP-1-
dependent enhancer at the epidermal differentiation complex locus that estab-
lishes spatial interactions with numerous gene promoter regions at that locus.
Journal of Investigative Dermatology (2014) 134, 2307–2310. doi:10.1038/jid.2014.247
All somatic cells in a multicellular
organism share identical DNA content,
but demonstrate vastly different pheno-
types, as is required for tissue and organ
development and homeostasis. Such
differences are based on tissue-specific
programs of gene expression established
in multi-potent progenitor cells and their
differentiating progenies. In mammals,
gene expression programs are controlled
at multiple levels, including gene trans-
cription. Transcription of protein-coding
and the majority of protein noncoding
genes is regulated by binding of and
interactions between numerous regula-
tory proteins, RNA polymerase II, and
proximal and distal gene cis-regulatory
elements. The best studied type of func-
tional interaction between cis-regulatory
elements is spatial contact between
the gene core promoter and enhancer
regions, which may be separated by
hundreds of kilobase pairs, or they could
even be located on different chromo-
somes (Bulger and Groudine, 2011;
Harmston and Lenhard, 2013). Because
DNA is organized in a nuclear–protein
complex called chromatin, chromatin
structural remodeling is required to con-
trol protein binding to the regulatory
regions and to establish contact between
the distal and proximal gene regulatory
elements (Rando and Chang, 2009).
Proper higher-order chromatin folding
in the three-dimensional (3D) nuclear
space is important in establishing func-
tional interactions between the promo-
ters and enhancers involved in controll-
ing cell-type–specific gene transcription
for numerous genes, including Shh, as
well as the genes that constitute the
b-globin, a-globin, and Hox gene loci
(Bulger and Groudine, 2011; Gibcus
and Dekker, 2013). Genome-wide asso-
ciation studies have demonstrated that
many single-nucleotide polymorphisms
identified in the intergenic regions are
associated with human diseases, sug-
gesting that such defects might perturb
normal gene expression programs by
affecting distal gene cis-regulatory ele-
ments (Maurano et al., 2012).
Functionally related and coregulated
genes often form multi-gene loci in
mammalian genomes. Genes involved
in execution of keratinocyte-specific
gene expression programs are clustered
in at least three evolutionally conserved
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regions, including the epidermal differ-
entiation complex (EDC) and Keratin
type I and type II loci. However, mole-
cular mechanisms involved in coordi-
nated gene regulation at these loci
remain largely unknown. In this issue,
Guzman-Strong and her team report on
the characterization of the epidermis-
specific enhancer 923 within the EDC
locus (Oh et al., 2014). They show that
this enhancer has tissue-specific activity
in transgenic mice and that it is active in
both proliferating and differentiating
murine keratinocytes in culture. Using
chromatin conformation capture (3C)
technology they demonstrate that this
enhancer forms spatial interactions
with the promoter regions of many
genes within the EDC in primary
keratinocyte cultures and that some,
but not all, of these contacts depend
on culture conditions (proliferative
versus differentiating). Finally, their
data reveal that binding of the AP-1
transcription factor to the enhancer
region is important for enhancer
element activity and establishment of
some, but not all, spatial contacts with
gene promoters.
Regulation of gene transcription by
enhancers
Most regulatory information required for
spatial and temporal control of gene
transcription programs in metazoans is
located outside core promoters within
distal gene regulatory elements. Among
these regulatory elements, the best stu-
died are enhancers, which are DNA
regions enriched in binding of transcrip-
tion factors and chromatin remodelers
that can increase transcription rates of
target genes in a manner that is inde-
pendent from distance to and orienta-
tion of the targeted promoter.
Several relatively common genetic
and epigenetic features of enhancers
allow their identification in the genome.
They are frequently located in the non-
coding elements that are highly con-
served across different mammalian
species (Bulger and Groudine, 2011;
Harmston and Lenhard, 2013). This
feature was used initially to identify
the 923 enhancer characterized by
Guzman-Strong’s team (Oh et al.,
2014). Functional enhancers are usually
located in the DNase I hypersensitive
regions of chromatin because of the
binding of multiple nonhistone proteins.
In paused and active enhancers, there is
a high level of mono-methylated lysine
4 in the histone H3 tail (H3K4me1),
whereas active enhancers also show
high levels of acetylated lysine 27 in
the histone H3 (H3K27ac) (Bulger
and Groudine, 2011; Harmston
and Lenhard, 2013). Oh et al. (2014)
demonstrated clearly that the 923
enhancer is active in epidermal
keratinocytes, both in vitro and in vivo,
and that this activity depends on the
transcription factor AP-1.
One of the major questions in enhan-
cer biology concerns the mechanisms
that underlie the interaction between
enhancers with target genes, and this
highlights the importance of higher-
order chromatin folding and spatial
organization of genes and enhancers
within the nucleus for the control of
gene transcription.
Higher-order chromatin folding, 3D
genome organization, and control of gene
expression
Progress in the analysis of higher-order
chromatin folding and 3D genome orga-
nization has been achieved using two
approaches. The first is confocal micro-
scopy after 3D fluorescence in situ
hybridization or gene loci labeling in
live cells using transgenic fluorescent
chimeric proteins that contain specific
DNA-binding domains (Cremer and
Cremer, 2010). The second is 3C
technology and its modifications, based
on the restriction digestion of chromatin
cross-linked using formaldehyde, follo-
wed by ligation at very low chromatin
concentrations to allow the formation of
intramolecular, but not intermolecular,
products (Dekker et al., 2013). The
original 3C technology provides infor-
mation about spatial interaction between
two selected genomic regions, often
referred to as a ‘‘one versus one’’ appr-
oach. The high-throughput modifications
of this technology include circular
chromatin conformation capture (4C) te-
chnology, allowing analysis of spatial
interaction of a single genomic site with
all other regions of the genome (‘‘one
versus all’’ approach), chromatin con-
formation capture carbon copy (5C)
technology, allowing analysis of spatial
interactions between a set of selected
genomic regions and another set of the
selected regions (‘‘many versus many’’
approach), and Hi-C technology, pro-
viding information about interac-
tions between all genomic regions (‘‘all
versus all’’ approach) (de Wit and de
Laat, 2012). These studies have revealed
that chromosomes are organized into
chromosome territories in the inter-
phase nucleus and that many genes are
not distributed randomly within the 3D
nuclear space.
Accumulating evidence suggests that
signaling/transcription factor–mediated
and epigenetic gene regulatory mech-
anisms are intimately connected
(Botchkarev et al., 2012). In the deve-
loping epidermis, transcription factor
p63 and ATP-dependent chromatin
remodeler Brg1 are required for EDC
locus relocation from the nuclear peri-
phery toward the nuclear interior in
epidermal progenitor cells (Mardaryev
et al., 2014). Furthermore, the global
Clinical Implications
Many genetic defects associated with human disease are located in
noncoding regions, and they involve gene enhancers and other distal
gene regulatory elements.
 Characterization of the 923 enhancer and its target genes at the epidermal
differentiation complex locus will provide new tools to understand
genetic defects associated with skin disease.
 Combining new high-throughput methodological approaches to study
correlations between genetic variations, gene expression programmes,
and genome-wide chromatin structural states in defined populations of
the cutaneous epithelial cells will provide new insight into the etiologies
of skin disease.
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genome organizer Satb1 serves as a
direct p63 target that controls the
establishment of proper conformations
of the EDC central domain (Fessing
et al., 2011). These data demonstrate
that higher-order chromatin remodeling
is important for the control of gene
expression at this locus.
Results generated by Oh et al. (2014)
further support this paradigm. They
demonstrate that the 923 enhancer
forms specific spatial contacts with the
subset of genes in the EDC in mouse
primary keratinocytes cultured under
proliferative and differentiating condi-
tions. These contacts depend partially
on the culturing conditions and binding
of the AP-1 transcription factor to the
enhancer. This finding provides the first
clue about mechanisms that underlie
the formation of enhancer–promoter
interactions in the EDC.
However, the mechanisms of estab-
lishing spatial chromatin contacts
between proximal and distal gene reg-
ulatory elements remain poorly under-
stood (Gibcus and Dekker, 2013). The
GATA-1 transcription factor and FOG-1
cofactor are clearly involved in
establishing contacts between the locus
control region and the gene promoters
at the b-globin gene locus (Vakoc et al.,
2005). However, studies in mouse
embryonic stem and neuronal progeni-
tor cells using high-throughput 5C
technology demonstrated that the inter-
acting chromatin regions are not
enriched with the binding of the
several analyzed transcription factors
alone or in different combinations
(Phillips-Cremins et al., 2013). Instead,
the interacting regions are enriched in
binding of the chromatin architectural
proteins CTCF and cohesin for the long-
range constitutive interactions shared by
embryonic stem cells and neuronal
progenitors. In contrast, in embryonic
stem cells, specific enhancer–promoter
interactions are enriched by combina-
tion of the mediator complex and cohe-
sin binding or cohesin binding alone.
These data suggest that combination of
chromatin architectural proteins and
the regulatory mediator complex might
have an important role in 3D chromatin
interactions.
Recent studies suggest that Satb1 is an
additional architectural protein involved
in interactions in the EDC in keratino-
cytes (Fessing et al., 2011). Oh et al.
(2014) demonstrate that the transcription
factor AP-1 also has a role in this process.
Most likely, mechanisms controlling
higher-order chromatin folding might
involve a combination of chromatin
architectural proteins and transcription
factors bound at interacting regions.
Application of the 3C (‘‘one versus
one’’) technology used by Oh et al.
(2014) is an important step toward
analyses of global higher-order chro-
matin folding at the EDC locus at
high resolution by employing high-
throughput 4C or 5C technologies. The
comprehensive genome-wide interac-
tome in different populations of
epidermal and hair follicle cells could
be analyzed using Hi-C (‘‘all versus all’’)
technology; however, the resolution of
this technology is limited by the cost
of high-throughput sequencing (Dekker
et al., 2013). Ultimately, high-throughput
modifications of 3C technology will help
answer many important questions about
the control of higher-order chromatin
folding at the EDC and other genomic
regions in different populations of the
skin epithelial cells and how folding
controls gene transcription programs by
defining spatial interactions between
proximal and distal gene regulatory
regions.
Recent studies demonstrate that mam-
malian genomes are compartmentalized
spatially at several different scales,
including global segregation of active
and inactive genomic domains, chro-
mosomal territories, topologically asso-
ciated domains (TADs) and subdomains
(sub-TADs; Gibcus and Dekker, 2013).
TADs are genomic regions from several
hundred Kbs to two Mbs in size, where
the spatial interactions within domains
are much more frequent compared with
between domains. Interestingly, the
borders of more than 90% of TADs are
cell-type invariant. Further studies using
high-throughput 5C or Hi-C technolo-
gies will help identify the organization
of the chromatin in TADs and sub-TADs
at the EDC.
Finally, interesting features of spatial
genome organization are interaction of
a single promoter with multiple enhan-
cers and interaction of an enhancer
with multiple promoters, suggesting the
presence of complex gene regulatory
element networks (Gibcus and Dekker,
2013). The 923 enhancer described by
Guzman-Strong’s team is one of several
distal gene regulatory elements controll-
ing coordinated gene transcription at the
EDC. Future studies will help identify
the spatial interactions between different
proximal and distant gene regulatory
elements in keratinocytes and assess
their roles in gene expression in skin
disease.
Conclusion
Recent technological and methodologi-
cal advances have advanced our knowl-
edge of higher-order chromatin folding
in the control of gene expression pro-
grams in mammals in health and dis-
ease, and they have raised many
exciting questions that can now be
addressed. New knowledge about 3D
genome organization and its role in
gene regulation in skin will lead to
new understanding of fundamental bio-
logical processes, and they will form a
basis for the development of novel
therapeutic and diagnostic tools to com-
bat skin disease.
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Keratinocyte Growth Regulation
TRP-ed Up Over Downregulated
TRPV4?
Wolfgang Liedtke1, Jennifer Y. Zhang2, Russell P. Hall III2 and Martin Steinhoff3
This commentary on an exciting new study (Fusi et al., 2014) puts the finding of
TRPV4 downregulation in several nonmelanoma skin cancers into context. The
original paper point toward possible use of TRPV4 as dermatopathologic marker,
also toward the possibility that downregulated TRPV4 can affect biological
properties of the cancer, by enhancing, but also regulating tumor growth. As
calcium-permeable TRPV4 has recently been identified as UVB-receptor in skin
keratinocytes, where it regulates skin tissue injury and pain after UVB over-
exposure, it is discussed whether TRPV4 downregulation can also be found in
other non-UVB-exposed cancers.
Journal of Investigative Dermatology (2014) 134, 2310–2312. doi:10.1038/jid.2014.250
In this issue of JID, an exciting new study
by Daniela Massi’s and Romina Nassini’s
groups at the University of Florence, Italy,
shows that keratinocytes from precancer-
ous lesions and from malignant skin
cancers exhibit considerable downregu-
lation of TRPV4 ion channels (Fusi et al.,
2014). Because sweat glands and endo-
thelial cells function as endogenous
positive controls, their finding suggests
that TRPV4 immunolabeling could be
a novel tissue marker in several skin
cancers and could improve diagnostic
accuracy in dermatopathology. How-
ever, the approach’s specificity needs to
be confirmed by examining additional
controls such as proliferative noninflam-
matory lesions (e.g., seborrheic keratosis
and verruca vulgaris), as well as healthy
skin proximal to cancer. Such a broad
study would also allow investigators to
correlate clinical features of a cancer with
the extent of TRPV4 downregulation.
Relevance for other epithelial tumors
with TRPV4 expression in the epithelium
before tumorigenesis
The question arises whether TRPV4 down-
regulation is restricted to skin cancer,
whereas other cancers, in which TRPV4
shows physiological epithelial expres-
sion, might not share this regulation. If
this were so, then epidermis-specific
TRPV4 downregulation in neoplastic
(or hyperproliferative) epithelia might
be associated with UVB exposure. Skin
is often UVB exposed, but intra-oral,
esophageal, and colonic epithelia—all
of which express TRPV4—are not. In
other words, does TRPV4 downregula-
tion in epithelia selectively affect UVB
carcinogenesis? Moreover, is TRPV4
downregulation in skin cancer ultimately
caused by UVB exposure? Chronically
UVB-damaged epidermis will be rele-
vant, where initial studies have demon-
strated TRPV4 upregulation (Moore et al.,
2013).
Does downregulation of the UV receptor,
TRPV4, protect UVB-exposed
keratinocytes against calcium
overexposure—or is it only an
epiphenomenon?
We can now consider whether in kerati-
nocytes UVB exposure and downregula-
tion of expression of a channel that is
activated by UVB—TRPV4 (Moore et al.,
2013)—are linked in an autoregulatory
feedback loop. TRPV4 downregulation
would protect the cell against an over-
abundance of calcium, and, in the con-
text of UVB exposure, against (detrimental)
consequences of UVB-mediated inflamma-
tion (including neurogenic inflammation)
and tissue injury. However, because
keratinocytes’ TRPV4 expression normally
facilitates calcium influx, which is also
known to sustain the layered architecture
of the epidermis by regulating keratinocyte
proliferation and differentiation (Yuspa
et al., 1989), TRPV4 downregulation may
represent cause, effect, or coincidence.
First, TRPV4 downregulation might
enable dedifferentiation and uncontrol-
led growth of keratinocytes, thus leading
to a malignant phenotype. Alternatively,
it may be a regulatory response of
malignantly transformed cells. We
can entertain the concept that TRPV4
downregulation is a counter-regulatory
mechanism of the malignantly trans-
formed cell because the stratified archi-
tecture of cancerous epithelia has been
lost, and calcium influx would fuel
growth, migration, and metastasis of
(pre) cancerous cells. Finally, it may be
an epiphenomenon without critical rele-
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